Richard G. Vincent - Mar 24, 2022 Form 4 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Chief Financial Officer
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Stock symbol
ONCT
Transactions as of
Mar 24, 2022
Transactions value $
$7,210
Form type
4
Date filed
3/28/2022, 04:00 PM
Previous filing
Jan 31, 2022
Next filing
Aug 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Purchase $4.35 +3 +0% $1.45 83.2K Mar 24, 2022 Direct
transaction ONCT Common Stock Purchase $516 +356 +0.43% $1.45 83.5K Mar 25, 2022 Direct
transaction ONCT Common Stock Purchase $7.40 +5 +0.01% $1.48 83.5K Mar 25, 2022 Direct
transaction ONCT Common Stock Purchase $3.18K +2.14K +2.56% $1.49 85.7K Mar 25, 2022 Direct
transaction ONCT Common Stock Purchase $3.5K +2.5K +2.92% $1.40 88.2K Mar 28, 2022 Direct
holding ONCT Common Stock 4.53K Mar 24, 2022 By Family Trust
holding ONCT Common Stock 1.83K Mar 24, 2022 By Child
* An asterisk sign (*) next to the price indicates that the price is likely invalid.